Estudio aleatorizado controlado de trimetoprimsulfametoxazol versus norfloxacino para la prevención de infecciones en pacientes cirróticos

Kinzel M, Francisca; Böhm G, Pauline; Sánchez F, Álvaro; Huenur F, Julieth; Quinteros M, Nicolás; Vergara B, Francisco; Arab V, Juan Pablo.
Gastroenterol. latinoam ; 28(2): 102-106, 2017. tab
Artículo en Español | LILACS | ID: biblio-1118758

Documentos relacionados

  1. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
  2. Systematic Review of Antimicrobial Lock Solutions for Prevention of Bacteremia in Pediatric Patients With Intestinal Failure.
  3. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
  4. Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis.
  5. [Spontaneous bacterial peritonitis in liver cirrhosis: optimization issues of prevention and treatment].
  6. Updates on Infectious and Other Complications in Peritoneal Dialysis: Core Curriculum 2023.
  7. Impact of bacterial infections and spontaneous bacterial peritonitis prophylaxis on phage-bacterial dynamics in cirrhosis.
  8. The Prevention of Carboxymethylcellulose on Bowel Adhesions Induced by Talc Peritonitis in Mice.
  9. [Systemic coagulopathic distress syndrome in surgery: concept, pathogenesis, prophylaxis].
  10. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.